Evidence map›Paper›PMID 29091133›Full record

ArticleMemorias do Instituto Oswaldo Cruz2017

Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract.

Beatriz Eugenia Fuentes-Castro, Juan Gerardo Reyes-García, María Teresa Valenzuela-Vargas, Federico Martínez-Gómez

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Endogenous cathelicidin protects againstInfection and immunity · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The effects of intracellular iron availability on the outcome ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  9. Article
  10. Article
  11. Exploring the Antiparasitic Activity ofMolecules (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  14. Article
  15. Article
  16. Viability ofVeterinary world · 2022
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Beatriz Eugenia Fuentes-CastroInstituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Departamento de Parasitología, Ciudad de México, México.
Juan Gerardo Reyes-GarcíaInstituto Politécnico Nacional, Escuela Superior de Medicina, Sección de Estudios de Posgrado e Investigación, Ciudad de México, México.
María Teresa Valenzuela-VargasInstituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Departamento de Morfología, Ciudad de México, México.
Federico Martínez-GómezInstituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Departamento de Parasitología, Ciudad de México, México.
Instituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDialyzable leukocyte extracts (DLEs) contain molecules smaller than 10 kDa with biological activity in receptor organisms. Primarily, they participate in the regulation of the Th1 immune response, which is essential for the control of several intracellular infections, such as toxoplasmosis. This disease is associated with congenital infection, encephalitis or systemic infections in immunocompromised individuals. The clinical course of this infection fundamentally depends on a well-regulated immune response and timely treatment with the appropriate drugs.

objectiveThe aim of this study was to evaluate the effect of treatment with a leukocyte extract, derived from crocodile lymphoid tissue, on the histopathology and brain parasite load in NIH mice that had been infected with cysts of Toxoplasma gondii (ME-49 strain).

methodsThe treatment was applied during the acute and chronic stages of the infection. Histopathological changes were evaluated in the ileum, liver and spleen at one, four and eight weeks after infection and in the brain at week 8. The parasite load was evaluated by counting the cysts of T. gondii found in the brain.

findingsCompared to the control mouse group, the mice infected with T. gondii and under treatment with DLE showed less tissue damage, mainly at the intestinal, splenic and hepatic levels. In addition, a greater percentage of survival was observed, and there was a considerable reduction in the parasite load in the brain.

conclusionsThe results suggest that DLE derived from crocodile is a potential adjunctive therapy in the conventional treatment of toxoplasmosis.

Indexed as

Alligators and CrocodilesAnimalsBrainDisease Models, AnimalFemaleLymphoid TissueMiceParasite LoadRandom AllocationSpleenToxoplasmosis, AnimalTransfer FactorTransfer Factor

Identifiers

PMID29091133
PMCPMC5661896
OpenAlexW2765745974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.